ZA200706751B - A method of modulating T cell functioning - Google Patents

A method of modulating T cell functioning

Info

Publication number
ZA200706751B
ZA200706751B ZA200706751A ZA200706751A ZA200706751B ZA 200706751 B ZA200706751 B ZA 200706751B ZA 200706751 A ZA200706751 A ZA 200706751A ZA 200706751 A ZA200706751 A ZA 200706751A ZA 200706751 B ZA200706751 B ZA 200706751B
Authority
ZA
South Africa
Prior art keywords
modulating
cell functioning
functioning
cell
Prior art date
Application number
ZA200706751A
Other languages
English (en)
Inventor
Steinman Lawrence
Platten Michael
Ho Peggy Pui-Kay
Michael L Selley
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of ZA200706751B publication Critical patent/ZA200706751B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
ZA200706751A 2005-01-14 2006-01-12 A method of modulating T cell functioning ZA200706751B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64450205P 2005-01-14 2005-01-14

Publications (1)

Publication Number Publication Date
ZA200706751B true ZA200706751B (en) 2008-10-29

Family

ID=36678226

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200706751A ZA200706751B (en) 2005-01-14 2006-01-12 A method of modulating T cell functioning

Country Status (10)

Country Link
EP (2) EP2253313A1 (pt)
JP (1) JP2008526983A (pt)
KR (1) KR20070098916A (pt)
CN (1) CN101232878A (pt)
AU (1) AU2006204871A1 (pt)
BR (1) BRPI0605925A2 (pt)
CA (1) CA2594460A1 (pt)
IL (1) IL184523A0 (pt)
WO (1) WO2006076580A2 (pt)
ZA (1) ZA200706751B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2030617A1 (en) * 2007-08-17 2009-03-04 Sygnis Bioscience GmbH & Co. KG Use of tranilast and derivatives thereof for the therapy of neurological conditions
FR3055548B1 (fr) 2016-09-05 2018-09-28 Metabrain Research Utilisation de metabolites du tryptophane dans le traitement de l'atrophie musculaire
CN110607335B (zh) * 2018-06-14 2021-08-03 中国科学院微生物研究所 一种烟酰胺腺嘌呤二核苷酸类化合物生物合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5640710B2 (pt) 1973-01-18 1981-09-22
EP1369114A1 (en) * 2002-06-07 2003-12-10 Peter Priv. Doz. Dr. Terness Use of tryptophan metabolites as pharmaceutical agents
US20050239892A1 (en) * 2003-11-21 2005-10-27 Trustees Of Tufts College Therapeutic avenathramide compounds
US20100041756A1 (en) * 2004-11-17 2010-02-18 Michael Lionel Selley method of modulating b cell functioning

Also Published As

Publication number Publication date
EP2253313A1 (en) 2010-11-24
IL184523A0 (en) 2008-12-29
WO2006076580A2 (en) 2006-07-20
KR20070098916A (ko) 2007-10-05
AU2006204871A1 (en) 2006-07-20
CA2594460A1 (en) 2006-07-20
EP1845967A4 (en) 2008-03-05
JP2008526983A (ja) 2008-07-24
EP1845967A2 (en) 2007-10-24
BRPI0605925A2 (pt) 2009-05-26
CN101232878A (zh) 2008-07-30
WO2006076580A3 (en) 2007-07-12

Similar Documents

Publication Publication Date Title
IL183192A0 (en) A method of modulating b cell functioning
EP1924146A4 (en) METHOD FOR CELLULAR IMPLANTATION
EP1880546A4 (en) STRATEGIES FOR THE DISTRIBUTION OF MULTIMEDIA EVENTS BANDWIDTH CONSUMERS
GB0522477D0 (en) Modulator
IL193841A0 (en) Methods for modulating bladder function
IL184262A (en) A method for culturing cells in culture
AU302286S (en) Seal
ZA200605397B (en) Reactor sealing methods
ZA200810214B (en) A teaching aid
GB0417382D0 (en) Seal
IL184523A0 (en) A method of modulating t cell functioning
PL1788077T3 (pl) Sposób tworzenia klastrów komórek
GB0519848D0 (en) A method of trading
GB0503918D0 (en) Cell
GB0607671D0 (en) Method for modulating a signal
HK1105280A (en) A method of modulating t cell functioning
AP1887A (en) An electrode and a method for forming an electrode
GB0411920D0 (en) A face seal
GB2424776B (en) Method for switching a power amplifier
GB0511058D0 (en) A method of controlling power
GB0525551D0 (en) Spring-energised seal
GB0625492D0 (en) A teaching aid
TWI371487B (en) A fast method of transforming competent cells
GB0401019D0 (en) A seal
HK1118446A (en) A method for cell implantation